Thinking of joining a study?

Register your interest

NCT06115486 | RECRUITING | Breast Cancer


EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer
Sponsor:

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Information provided by (Responsible Party):

Colin Champ, MD

Brief Summary:

The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.

Condition or disease

Breast Cancer

Breast Carcinoma in Situ

Breast Cancer Female

Intervention/treatment

Control Arm ACSM Guidelines

Experimental Arm 6-12-25 repetitions per set

Phase

NA

Detailed Description:

This protocol seeks to analyze patient outcomes of two standard of care, time-efficient, monitored group exercise regimens of high-load resistance training to improve hypertrophy in women who have been treated for ductal carcinoma in situ or invasive carcinoma of the breast. As part of the standard exercise program, patients will undergo a fitness evaluation at the AHNCI Exercise Oncology and Resiliency Center before the start of the exercise program. This evaluation will be used to customize the patient exercise program. The exercise program consists of small group training sessions held approximately 3 times per week at the center for 12 weeks (3 months). The fitness evaluation and exercise program are standard of care. Participation in this study will last the duration of the exercise program, about 3 months. All group exercise sessions will be closely monitored by the center staff who are Certified Strength and Conditioning Specialists (CSCS).

Study Type : INTERVENTIONAL
Estimated Enrollment : 30 participants
Masking : NONE
Primary Purpose : OTHER
Official Title : EXERT-BCH: Prospective Study of EXErcise Regimens After Treatment for Breast Cancer to Improve Hypertrophy
Actual Study Start Date : 2024-01-09
Estimated Primary Completion Date : 2027-01
Estimated Study Completion Date : 2027-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 20 Years to 89 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • Age 20-89 years
  • * Women with a biopsy proven diagnosis of ductal carcinoma in situ or invasive carcinoma of the breast
  • * Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.
Exclusion Criteria
  • * Any current treatment with cytotoxic chemotherapy for breast cancer
  • * Inability to safely engage in group sessions of resistance training as deemed by study PI
  • * Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

Location Details

NCT06115486


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Pennsylvania

Allegheny General Hospital

Pittsburgh, Pennsylvania, United States, 15212

Loading...